| T1 | T2 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
# Tested n | # Mild n (%) | # Moderate n (%) | # Severe n (%) | % Affected | # Tested n | # Mild n (%) | # Moderate n (%) | # Severe n (%) | % Affected | |
Sudomotor function | ||||||||||
Patients | 13 | 2 (15.4) | 0 (0.0) | 2 (15.4) | 30.8 | 12 | 4 (33.3) | 0 (0.0) | 0 (0.0) | 33.3 |
Controls | 12 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 11 | 1 (9.1) | 0 (0.0) | 0 (0.0) | 9.1 |
Cardiovagal function | ||||||||||
Patients | 12 | 0 (0.0) | 2 (16.7) | 3 (25.0) | 41.7 | 11 | 2 (18.2) | 1 (9.1) | 0 (0.0) | 27.3 |
Controls | 12 | 1 (8.3) | 0 (0.0) | 0 (0.0) | 8.3 | 11 | 1 (9.1) | 1 (9.1) | 0 (0.0) | 18.2 |
Adrenergic function | ||||||||||
Patients | 11 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.0 | 12 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.0 |
Controls | 12 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.0 | 11 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.0 |